Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

Interleukin-12 Antagonists [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
51407-929 IMULDOSA ustekinumab-srlf Golden State Medical Supply, Inc. INJECTION 2024-10-10
51407-930 IMULDOSA ustekinumab-srlf Golden State Medical Supply, Inc. INJECTION 2024-10-10
51407-931 IMULDOSA ustekinumab-srlf Golden State Medical Supply, Inc. INJECTION 2024-10-10
57894-054 Stelara ustekinumab Janssen Biotech, Inc. SOLUTION 2016-09-23
57894-060 STELARA ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2009-09-25
57894-061 STELARA ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2009-09-25
57894-440 ustekinumab ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2025-04-01
57894-441 ustekinumab ustekinumab Janssen Biotech, Inc. INJECTION, SOLUTION 2025-04-01
57894-444 ustekinumab ustekinumab Janssen Biotech, Inc. SOLUTION 2025-04-01
61314-651 PYZCHIVA ustekinumab-ttwe SANDOZ INC INJECTION, SOLUTION 2025-02-22
61314-652 PYZCHIVA ustekinumab-ttwe SANDOZ INC INJECTION, SOLUTION 2025-02-22
61314-654 PYZCHIVA ustekinumab-ttwe SANDOZ INC INJECTION, SOLUTION 2025-02-22
65219-822 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC INJECTION, SOLUTION 2025-09-29
65219-824 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC INJECTION, SOLUTION 2024-02-22
65219-826 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC INJECTION, SOLUTION 2024-02-22
65219-828 Otulfi ustekinumab-aauz Fresenius Kabi USA, LLC SOLUTION 2024-02-22
69448-017 IMULDOSA ustekinumab-srlf Accord BioPharma Inc. INJECTION 2024-10-14
69448-018 IMULDOSA ustekinumab-srlf Accord BioPharma Inc. INJECTION 2024-10-14
69448-019 IMULDOSA ustekinumab-srlf Accord BioPharma Inc. INJECTION 2024-10-18
82009-160 USTEKINUMAB-TTWE ustekinumab-ttwe Quallent Pharmaceuticals Health LLC INJECTION, SOLUTION 2025-04-15
82009-162 USTEKINUMAB-TTWE ustekinumab-ttwe Quallent Pharmaceuticals Health LLC INJECTION, SOLUTION 2025-04-15
82009-163 USTEKINUMAB-TTWE ustekinumab-ttwe Quallent Pharmaceuticals Health LLC INJECTION, SOLUTION 2025-04-15
83257-023 YESINTEK ustekinumab Biocon Biologics Inc. INJECTION, SOLUTION 2025-02-22
83257-024 YESINTEK ustekinumab Biocon Biologics Inc. INJECTION, SOLUTION 2025-02-22
83257-025 YESINTEK ustekinumab Biocon Biologics Inc. INJECTION, SOLUTION 2025-02-22
83257-026 YESINTEK ustekinumab Biocon Biologics Inc. SOLUTION 2025-02-22
83457-651 PYZCHIVA ustekinumab-ttwe Cordavis Limited INJECTION, SOLUTION 2025-05-01
83457-652 PYZCHIVA ustekinumab-ttwe Cordavis Limited INJECTION, SOLUTION 2025-05-01
83457-654 PYZCHIVA ustekinumab-ttwe Cordavis Limited INJECTION, SOLUTION 2025-05-01
84612-055 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-066 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-076 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-089 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-855 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-876 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01
84612-889 WEZLANA ustekinumab-auub Optum Health Solutions (Ireland) Limited INJECTION, SOLUTION 2025-01-01

 Mechanism of Action Classification 

Loading full table content...